Heparin and heparan sulphate oligosaccharides
US11331337B2 · kind B2 · utility
1Cited by
0References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2018 |
| Grant date | May 17, 2022 |
| Priority date | — |
| Expiry date | Dec 11, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isolated heparin or heparan sulphate oligosaccharide fragments having a chain length of at least 10 saccharides and no more than 50 saccharides, which are capable of binding BMP2, are disclosed. Also disclosed is the use of the same heparin or heparan sulphate oligosaccharide fragments in kits and pharmaceutical compositions, and the use of the same heparan sulphate oligosaccharide fragments in the repair and/or regeneration of connective tissue and bones, and the treatment of wounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.